Sanford Glantz, MD - Medicare Emergency Medicine in West Islip, NY

Sanford Glantz, MD is a medicare enrolled "Emergency Medicine" physician in West Islip, New York. His current practice location is 1000 Montauk Hwy, West Islip, New York. You can reach out to his office (for appointments etc.) via phone at (631) 376-3000.

Sanford Glantz is licensed to practice in New York (license number 154331) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1124042668.

Contact Information

Sanford Glantz, MD
1000 Montauk Hwy,
West Islip, NY 11795-4927
(631) 376-3000
Not Available



Physician's Profile

Full NameSanford Glantz
GenderMale
SpecialityEmergency Medicine
Location1000 Montauk Hwy, West Islip, New York
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1124042668
  • Provider Enumeration Date: 07/27/2006
  • Last Update Date: 08/25/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 2264533306
  • Enrollment ID: I20141224001200

Medical Identifiers

Medical identifiers for Sanford Glantz such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1124042668NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 154331 (New York)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sanford Glantz allows following entities to bill medicare on his behalf.
Entity NameKeystone Medical Services Of Ms Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174691059
PECOS PAC ID: 7618075177
Enrollment ID: O20070606000447

News Archive

Researchers find new therapeutic target of biomedical interest in ischemic injury research

An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.

NTRR completes research and development of new erectile dysfunction treatment

With Neutra Corp.'s Pure Plus weight-loss supplement already in the midst of clinical trials, the company announced today that it has completed research and development of its next product in the Pure Plus line: an all-natural erectile dysfunction (ED) treatment.

Scientists to discuss effective treatments for serious diseases at Functional Genomics/Chemical Biology conference

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

U.N. calls for $1.4B to fund basic needs in Haiti through the end of 2010

The U.N. on Thursday launched its "largest appeal following a natural disaster," calling for $1.4 billion "to provide food, water, shelter and sanitation to 3 million Haitians throughout 2010," Bloomberg/BusinessWeek reports (Varner, 2/18).

Read more Medical News

› Verified 2 days ago

Entity NameKeystone Medical Services Of Gulfport Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881070183
PECOS PAC ID: 7113221011
Enrollment ID: O20160215000517

News Archive

Researchers find new therapeutic target of biomedical interest in ischemic injury research

An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.

NTRR completes research and development of new erectile dysfunction treatment

With Neutra Corp.'s Pure Plus weight-loss supplement already in the midst of clinical trials, the company announced today that it has completed research and development of its next product in the Pure Plus line: an all-natural erectile dysfunction (ED) treatment.

Scientists to discuss effective treatments for serious diseases at Functional Genomics/Chemical Biology conference

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

U.N. calls for $1.4B to fund basic needs in Haiti through the end of 2010

The U.N. on Thursday launched its "largest appeal following a natural disaster," calling for $1.4 billion "to provide food, water, shelter and sanitation to 3 million Haitians throughout 2010," Bloomberg/BusinessWeek reports (Varner, 2/18).

Read more Medical News

› Verified 2 days ago

Entity NameMedical Services Of Meridian Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174095988
PECOS PAC ID: 7315285376
Enrollment ID: O20190218000483

News Archive

Researchers find new therapeutic target of biomedical interest in ischemic injury research

An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.

NTRR completes research and development of new erectile dysfunction treatment

With Neutra Corp.'s Pure Plus weight-loss supplement already in the midst of clinical trials, the company announced today that it has completed research and development of its next product in the Pure Plus line: an all-natural erectile dysfunction (ED) treatment.

Scientists to discuss effective treatments for serious diseases at Functional Genomics/Chemical Biology conference

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

U.N. calls for $1.4B to fund basic needs in Haiti through the end of 2010

The U.N. on Thursday launched its "largest appeal following a natural disaster," calling for $1.4 billion "to provide food, water, shelter and sanitation to 3 million Haitians throughout 2010," Bloomberg/BusinessWeek reports (Varner, 2/18).

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sanford Glantz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sanford Glantz, MD
Po Box 6010,
Hauppauge, NY 11788-9010

Ph: (631) 232-4000
Sanford Glantz, MD
1000 Montauk Hwy,
West Islip, NY 11795-4927

Ph: (631) 376-3000

News Archive

Researchers find new therapeutic target of biomedical interest in ischemic injury research

An international scientific team has developed a new small molecule -VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry of the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and Julianty Frost, from the University of Dundee.

NTRR completes research and development of new erectile dysfunction treatment

With Neutra Corp.'s Pure Plus weight-loss supplement already in the midst of clinical trials, the company announced today that it has completed research and development of its next product in the Pure Plus line: an all-natural erectile dysfunction (ED) treatment.

Scientists to discuss effective treatments for serious diseases at Functional Genomics/Chemical Biology conference

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

U.N. calls for $1.4B to fund basic needs in Haiti through the end of 2010

The U.N. on Thursday launched its "largest appeal following a natural disaster," calling for $1.4 billion "to provide food, water, shelter and sanitation to 3 million Haitians throughout 2010," Bloomberg/BusinessWeek reports (Varner, 2/18).

Read more News

› Verified 2 days ago


Emergency Medicine Doctors in West Islip, NY

Dr. Emilissa Jane Domingo, D.O.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 Montauk Hwy, West Islip, NY 11795
Phone: 631-376-4045    
Dr. Joseph Umberto Artale, D.O.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1000 Montauk Hwy, West Islip, NY 11795
Phone: 631-376-1000    
Dr. Genevieve Theresa Mcgerald, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 Montauk Hwy, West Islip, NY 11795
Phone: 631-376-4045    
Mr. Lucas Walker Lee, PA-C
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1000 Montauk Hwy, West Islip, NY 11795
Phone: 631-376-3000    
Geraldine Simons,
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 Montauk Hwy, West Islip, NY 11795
Phone: 631-376-4000    
Reine James,
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1000 Montauk Hwy, West Islip, NY 11795
Phone: 631-376-4000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.